FindTrial
Sign In

Study on placenta of women with coronavirus disease 2019 (COVID-19)

Study on placenta of women with coronavirus disease 2019 (COVID-19) and its correlation with pregnancy and neonatal outcomes

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/027862
Enrollment
150
Registered
2020-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere

Interventions

None listed

Sponsors

NWMH
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria Cases: 1.Pregnant women ( >18 years) with laboratory confirmed diagnosis (RT PCR of nasopharyngeal and throat swab) of COVID-19 2.Pregnant women who are willing to take part in study. Controls: Pregnant women ( >18 years) without any history of COVID-19 disease confirmed COVID -19 negative by laboratory diagnosis (RT PCR of nasopharyngeal and throat swab) within last 5 days.

Exclusion criteria

Exclusion criteria: Women not willing to take part in the study.

Design outcomes

Primary

MeasureTime frame
This study will provide first-hand information on the clinical course of COVID-19 in pregnancy and give an understanding of its pathogenesis. It will also provide an information of the possibility of vertical transmission of the virus via the placenta.Timepoint: Pregnancy outcome is studied at delivery and neonatal outcome at the end of one week—

Secondary

MeasureTime frame
Possibility of vertical transmission of SARS CoV- 2 through the placentaTimepoint: 36 months—

Countries

India

Contacts

Public ContactDr Ketki S Kulkarni

Nowrosjee Wadia Maternity Hospital

drketkiskulkarni@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026